BIOLASE Reports Strong Sequential Revenue Growth In Third Quarter 2020
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Biolase (BIOL) Reports Q3 Revenue of $6.5 million
November 12, 2020 4:27 PM ESTBiolase (NASDAQ: BIOL) reported Q3 EPS of ($0.21), versus ($0.25) reported last year. Revenue for the quarter came in at $6.54 million, versus $8.65 million reported last year.
Adjusted EBITDA loss for the third quarter of 2020 was $2.5 million, or $0.03 per share, compared with Adjusted EBITDA... More


